A
correction
to this article has been published: Galvez et al., J. Cell Biol. 175 (2) 361
A
correction
to this article has been published: Galvez et al., J. Cell Biol. 174 (4) 605
Published online 10 July 2006. doi:10.1083/jcb.200512085
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 174, Number 2, 231-243
Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability
Beatriz G. Galvez1,
Maurilio Sampaolesi1,2,
Silvia Brunelli1,3,
Diego Covarello1,
Manuela Gavina4,
Barbara Rossi6,
Gabriela Constantin6,
Yvan Torrente4, and
Giulio Cossu1,5
1 Stem Cell Research Institute, San Raffaele Hospital, 20132 Milan, Italy
2 Department of Experimental Medicine, Human Anatomy Institute, University of Pavia, 27100 Pavia, Italy
3 Department of Experimental, Environmental Medicine, and Medical Biotechnology, University of Milano-Bicocca, 20126 Milan, Italy
4 Stem Cell Laboratory, Department of Neurological Science, and 5 Department of Biology, University of Milan, 20122 Milan, Italy
6 Department of Pathology, Division of General Pathology, University of Verona, 37129 Verona, Italy
Correspondence to Giulio Cossu: cossu.giulio{at}hsr.it
Efficient delivery of cells to target tissues is a major problem in cell therapy. We report that enhancing delivery of mesoangioblasts leads to a complete reconstitution of downstream skeletal muscles in a mouse model of severe muscular dystrophy (
-sarcoglycan ko). Mesoangioblasts, vessel-associated stem cells, were exposed to several cytokines, among which stromal- derived factor (SDF) 1 or tumor necrosis factor (TNF)
were the most potent in enhancing transmigration in vitro and migration into dystrophic muscle in vivo. Transient expression of
4 integrins or L-selectin also increased several fold migration both in vitro and in vivo. Therefore, combined pretreatment with SDF-1 or TNF-
and expression of
4 integrin leads to massive colonization (>50%) followed by reconstitution of >80% of
-sarcoglycanexpressing fibers, with a fivefold increase in efficiency in comparison with control cells. This study defines the requirements for efficient engraftment of mesoangioblasts and offers a new potent tool to optimize future cell therapy protocols for muscular dystrophies.
Abbreviations used in this paper: ctx, cardiotoxin; HMGB, high mobility group box; ICAM, intercellular adhesion molecule; IL, interleukin; mdx, X chromosomelinked muscular dystrophy; MMP, metalloproteinase; PECAM, platelet endothelial cell adhesion molecule; SDF, stromal-derived factor; SG, sarcoglycan; VCAM, vascular cell adhesion molecule; WT, wild-type.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Article
-
Homing therapy
- Rabiya S. Tuma
J. Cell Biol. 2006 174: 164.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Lolmede, K., Campana, L., Vezzoli, M., Bosurgi, L., Tonlorenzi, R., Clementi, E., Bianchi, M. E., Cossu, G., Manfredi, A. A., Brunelli, S., Rovere-Querini, P.
(2009). Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J. Leukoc. Biol.
85: 779-787
[Abstract]
[Full Text]
-
Messina, G., Sirabella, D., Monteverde, S., Galvez, B. G., Tonlorenzi, R., Schnapp, E., De Angelis, L., Brunelli, S., Relaix, F., Buckingham, M., Cossu, G.
(2009). Skeletal Muscle Differentiation of Embryonic Mesoangioblasts Requires Pax3 Activity. Stem Cells
27: 157-164
[Abstract]
[Full Text]
-
Wallace, G. Q., Lapidos, K. A., Kenik, J. S., McNally, E. M.
(2008). Long-Term Survival of Transplanted Stem Cells in Immunocompetent Mice with Muscular Dystrophy. Am. J. Pathol.
173: 792-802
[Abstract]
[Full Text]
-
Dimmeler, S., Leri, A.
(2008). Aging and Disease as Modifiers of Efficacy of Cell Therapy. Circ. Res.
102: 1319-1330
[Abstract]
[Full Text]
-
Bae, G.-U., Gaio, U., Yang, Y.-J., Lee, H.-J., Kang, J.-S., Krauss, R. S.
(2008). Regulation of Myoblast Motility and Fusion by the CXCR4-associated Sialomucin, CD164. J. Biol. Chem.
283: 8301-8309
[Abstract]
[Full Text]
-
Mazzinghi, B., Ronconi, E., Lazzeri, E., Sagrinati, C., Ballerini, L., Angelotti, M. L., Parente, E., Mancina, R., Netti, G. S., Becherucci, F., Gacci, M., Carini, M., Gesualdo, L., Rotondi, M., Maggi, E., Lasagni, L., Serio, M., Romagnani, S., Romagnani, P.
(2008). Essential but differential role for CXCR4 and CXCR7 in the therapeutic homingof human renal progenitor cells. JEM
205: 479-490
[Abstract]
[Full Text]
-
Dimmeler, S., Burchfield, J., Zeiher, A. M.
(2008). Cell-Based Therapy of Myocardial Infarction. Arterioscler. Thromb. Vasc. Bio.
28: 208-216
[Abstract]
[Full Text]
-
Castaldi, L., Serra, C., Moretti, F., Messina, G., Paoletti, R., Sampaolesi, M., Torgovnick, A., Baiocchi, M., Padula, F., Pisaniello, A., Molinaro, M., Cossu, G., Levrero, M., Bouche, M.
(2007). Bisperoxovanadium, a phospho-tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype. FASEB J.
21: 3573-3583
[Abstract]
[Full Text]
-
De Mori, R., Straino, S., Di Carlo, A., Mangoni, A., Pompilio, G., Palumbo, R., Bianchi, M. E., Capogrossi, M. C., Germani, A.
(2007). Multiple Effects of High Mobility Group Box Protein 1 in Skeletal Muscle Regeneration. Arterioscler. Thromb. Vasc. Bio.
27: 2377-2383
[Abstract]
[Full Text]
-
Palumbo, R., Galvez, B. G., Pusterla, T., De Marchis, F., Cossu, G., Marcu, K. B., Bianchi, M. E.
(2007). Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-{kappa}B activation. JCB
179: 33-40
[Abstract]
[Full Text]
-
Bondesen, B. A., Jones, K. A., Glasgow, W. C., Pavlath, G. K.
(2007). Inhibition of myoblast migration by prostacyclin is associated with enhanced cell fusion. FASEB J.
21: 3338-3345
[Abstract]
[Full Text]
-
Brunelli, S., Sciorati, C., D'Antona, G., Innocenzi, A., Covarello, D., Galvez, B. G., Perrotta, C., Monopoli, A., Sanvito, F., Bottinelli, R., Ongini, E., Cossu, G., Clementi, E.
(2007). Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc. Natl. Acad. Sci. USA
104: 264-269
[Abstract]
[Full Text]
-
Sciorati, C., Galvez, B. G., Brunelli, S., Tagliafico, E., Ferrari, S., Cossu, G., Clementi, E.
(2006). Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J. Cell Sci.
119: 5114-5123
[Abstract]
[Full Text]
-
Morosetti, R., Mirabella, M., Gliubizzi, C., Broccolini, A., De Angelis, L., Tagliafico, E., Sampaolesi, M., Gidaro, T., Papacci, M., Roncaglia, E., Rutella, S., Ferrari, S., Tonali, P. A., Ricci, E., Cossu, G.
(2006). MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. Proc. Natl. Acad. Sci. USA
103: 16995-17000
[Abstract]
[Full Text]
-
Zammit, P. S., Partridge, T. A., Yablonka-Reuveni, Z.
(2006). The Skeletal Muscle Satellite Cell: The Stem Cell That Came in From the Cold. J. Histochem. Cytochem.
54: 1177-1191
[Abstract]
[Full Text]
-
Galvez, B. G., Sampaolesi, M., Brunelli, S., Covarello, D., Gavina, M., Rossi, B., Costantin, G., Torrente, Y., Cossu, G.
(2006). Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. JEM
203: i21-21
[Full Text]